5 February 2019

The GPCRdb contains data, diagrams and web tools for G protein-coupled receptors (GPCRs). This resource was founded by professor Gert Vriend, theme Nanomedicine, and is now maintained and expanded by the group of David Gloriam in Copenhagen.

The most recent addition to the GPCRdb is a web tool to make the design of crystal constructs easier. CMBI Master's student Janne Bibbe (photo) was part of this project, and is now co-author of the paper "An online resource for GPCR structure determination and analysis" in Nature Methods.

GPCRs are cell-surface receptors, and they are a very important drug target: 34% of all drugs approved in the US act on GPCRs. For rational drug design, structures of the receptors are needed. GPCRs are difficult to crystallize, because they are very flexible and hydrophobic. In the past decade, much progress has been made in measuring GPCR structures, but there is no structure for the majority of receptors (87%) and there is a lack in knowledge about the intermediate and active states of GPCRs. The GPCRdb now offers a tool that helps to design mutations, choose fusion proteins and choose experimental conditions in order to successfully crystallize a receptor.
 

Related news items


Jong KNCV organizes a Pitch competition for PhD candidates

13 August 2020

Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.

read more

Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels

13 August 2020

Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.

read more

TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer

12 August 2020

An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.

read more

BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea

11 August 2020

The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

read more

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more